chr17-36545769-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_024835.5(GGNBP2):c.45C>A(p.Phe15Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000838 in 1,431,486 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024835.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000506 AC: 10AN: 197724Hom.: 0 AF XY: 0.0000469 AC XY: 5AN XY: 106684
GnomAD4 exome AF: 0.00000838 AC: 12AN: 1431486Hom.: 0 Cov.: 30 AF XY: 0.00000705 AC XY: 5AN XY: 709542
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.45C>A (p.F15L) alteration is located in exon 2 (coding exon 1) of the GGNBP2 gene. This alteration results from a C to A substitution at nucleotide position 45, causing the phenylalanine (F) at amino acid position 15 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at